Rio de Janeiro, Brazil

Elaine Sobral Da Costa

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Rio de Janerio, BR (2008)
  • Rio de Janeiro, BR (2009)

Company Filing History:


Years Active: 2008-2009

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Elaine Sobral Da Costa: Innovator in Flow Cytometry

Introduction

Elaine Sobral Da Costa is a prominent inventor based in Rio de Janeiro, Brazil. She has made significant contributions to the field of flow cytometry, particularly in the detection of neoplastic cells. With a total of 2 patents, her work is paving the way for advancements in cancer monitoring and diagnostics.

Latest Patents

Elaine's latest patents include innovative methods for detecting aberrant phenotypes in neoplastic cells. One of her patents describes a method that involves staining normal and neoplastic samples with monoclonal antibodies, measuring fluorescence emissions, and identifying neoplastic cells in a multidimensional space. This method aims to monitor minimal disease levels effectively. Another patent focuses on generating new flow cytometry data files that contain an infinite number of dimensions based on data estimation. This method fuses separate flow cytometry data files and reconstructs multidimensional data files, enhancing the analysis of cellular events.

Career Highlights

Elaine has worked with esteemed institutions such as the University of Salamanca. Her research has significantly impacted the understanding of neoplastic cell behavior and the development of advanced diagnostic tools.

Collaborations

Elaine has collaborated with notable professionals in her field, including Carlos Eduardo Pedreira and José Alberto Orfao De Matos Correia E Vale. These collaborations have further enriched her research and innovations.

Conclusion

Elaine Sobral Da Costa is a trailblazer in the realm of flow cytometry, with her patents contributing to the early detection and monitoring of cancer. Her work exemplifies the intersection of innovation and healthcare, showcasing the potential for technology to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…